Registration

PIER STRATEGIES LLC for TEVA PHARMACEUTICALS USA

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to 'follow on' biologics legislation.

LobbyistCovered position, as disclosed
DAVID SCHWARZ New —

Pharmacy PHA

Issues related to 'follow on' biologics legislation.

LobbyistCovered position, as disclosed
DAVID SCHWARZ New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TEVA PHARMACEUTICALS EUROPE B.V. Netherlands Netherlands 100.0% —
TEVA PHARMACEUTICALS INDUSTRIES LTD. Israel Israel 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.